Compare SEZL & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SEZL | CAI |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1846 |
| Industry | Diversified Financial Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.0B |
| IPO Year | 2023 | N/A |
| Metric | SEZL | CAI |
|---|---|---|
| Price | $183.14 | $18.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $109.33 | $30.91 |
| AVG Volume (30 Days) | 637.3K | ★ 2.8M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $450,279,000.00 | N/A |
| Revenue This Year | $30.30 | $25.24 |
| Revenue Next Year | $24.79 | $22.32 |
| P/E Ratio | $124.80 | ★ N/A |
| Revenue Growth | ★ 66.08 | N/A |
| 52 Week Low | $49.50 | $14.19 |
| 52 Week High | $186.74 | $42.50 |
| Indicator | SEZL | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 80.37 | 54.28 |
| Support Level | $59.42 | $17.15 |
| Resistance Level | N/A | $19.79 |
| Average True Range (ATR) | 10.34 | 1.09 |
| MACD | 1.94 | 0.07 |
| Stochastic Oscillator | 97.14 | 46.98 |
Sezzle Inc is a financing institution that offers technology-driven payment platform. The Sezzle Platform offers a payments solution for consumers in the United States and Canada that has the ability to instantly extend credit at the point-of-sale, allowing consumers to purchase and receive merchandise while paying in installments over time. Consumers pay a portion of the purchase price at the point-of-sale as a down payment, and then pay off the remaining amount over time through scheduled payments. It also offer the ability to pay-in-full using the Sezzle Platform. Its operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.